Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shervin Assassi

Showing results (181-190 of 238) with videos related to

Pageof 24
Sort By:
Arthritis & Rheumatology (Hoboken, N.J.)|October 25, 2022
Three Distinct Transcriptional Profiles of Monocytes Associate with Disease Activity in Scleroderma PatientsHadijat-Kubura M Makinde, Julia L M Dunn, Gaurav Gadhvi, et al.
Journal of Autoimmunity|October 3, 2009
Association of the C8orf13-BLK region with systemic sclerosis in North-American and European populationsPravitt Gourh, Sandeep K Agarwal, Ezequiel Martin, et al.
Annals of the Rheumatic Diseases|October 2, 2020
Genomic Risk Score impact on susceptibility to systemic sclerosisLara Bossini-Castillo, Gonzalo Villanueva-Martin, Martin Kerick, et al.
Clinical and Experimental Rheumatology|August 6, 2016
Examination of the association of sex and race/ethnicity with appearance concerns: a Scleroderma Patient-centered Intervention Network (SPIN) Cohort studyLisa R Jewett, Linda Kwakkenbos, Marie-Eve Carrier, et al.
Annals of the Rheumatic Diseases|September 20, 2011
Novel identification of the IRF7 region as an anticentromere autoantibody propensity locus in systemic sclerosisF David Carmona, Ramana Gutala, Carmen P Simeón, et al.
The Lancet. Rheumatology|April 3, 2025
Serum type I interferon score as a disease activity biomarker in patients with diffuse cutaneous systemic sclerosis: a retrospective cohort studyMonique Hinchcliff, Dinesh Khanna, Enrico De Lorenzis, et al.
The Journal of Clinical Investigation|July 1, 2020
Long noncoding RNA H19X is a key mediator of TGF-β-driven fibrosisElena Pachera, Shervin Assassi, Gloria A Salazar, et al.
Journal of Clinical Medicine|October 27, 2022
The Effect of Body Fat Distribution on Systemic SclerosisGonzalo Villanueva-Martin, Marialbert Acosta-Herrera, Martin Kerick, et al.
The Journal of Investigative Dermatology|September 18, 2022
Reduced SPAG17 Expression in Systemic Sclerosis Triggers Myofibroblast Transition and Drives FibrosisPaulene Sapao, Elisha D O Roberson, Bo Shi, et al.
Annals of the Rheumatic Diseases|June 7, 2021
Comprehensive analysis of the major histocompatibility complex in systemic sclerosis identifies differential HLA associations by clinical and serological subtypesMarialbert Acosta-Herrera, Martin Kerick, Elena Lopéz-Isac, et al.
Pageof 24

Showing results (181-190 of 238) with videos related to

Sort By:
Pageof 24
Arthritis & Rheumatology (Hoboken, N.J.)|October 25, 2022
Three Distinct Transcriptional Profiles of Monocytes Associate with Disease Activity in Scleroderma PatientsHadijat-Kubura M Makinde, Julia L M Dunn, Gaurav Gadhvi, et al.
Journal of Autoimmunity|October 3, 2009
Association of the C8orf13-BLK region with systemic sclerosis in North-American and European populationsPravitt Gourh, Sandeep K Agarwal, Ezequiel Martin, et al.
Annals of the Rheumatic Diseases|October 2, 2020
Genomic Risk Score impact on susceptibility to systemic sclerosisLara Bossini-Castillo, Gonzalo Villanueva-Martin, Martin Kerick, et al.
Clinical and Experimental Rheumatology|August 6, 2016
Examination of the association of sex and race/ethnicity with appearance concerns: a Scleroderma Patient-centered Intervention Network (SPIN) Cohort studyLisa R Jewett, Linda Kwakkenbos, Marie-Eve Carrier, et al.
Annals of the Rheumatic Diseases|September 20, 2011
Novel identification of the IRF7 region as an anticentromere autoantibody propensity locus in systemic sclerosisF David Carmona, Ramana Gutala, Carmen P Simeón, et al.
The Lancet. Rheumatology|April 3, 2025
Serum type I interferon score as a disease activity biomarker in patients with diffuse cutaneous systemic sclerosis: a retrospective cohort studyMonique Hinchcliff, Dinesh Khanna, Enrico De Lorenzis, et al.
The Journal of Clinical Investigation|July 1, 2020
Long noncoding RNA H19X is a key mediator of TGF-β-driven fibrosisElena Pachera, Shervin Assassi, Gloria A Salazar, et al.
Journal of Clinical Medicine|October 27, 2022
The Effect of Body Fat Distribution on Systemic SclerosisGonzalo Villanueva-Martin, Marialbert Acosta-Herrera, Martin Kerick, et al.
The Journal of Investigative Dermatology|September 18, 2022
Reduced SPAG17 Expression in Systemic Sclerosis Triggers Myofibroblast Transition and Drives FibrosisPaulene Sapao, Elisha D O Roberson, Bo Shi, et al.
Annals of the Rheumatic Diseases|June 7, 2021
Comprehensive analysis of the major histocompatibility complex in systemic sclerosis identifies differential HLA associations by clinical and serological subtypesMarialbert Acosta-Herrera, Martin Kerick, Elena Lopéz-Isac, et al.
Pageof 24